← Back to news
Clinical trialCLINICALTRIALSThursday, April 30, 2026 · April 30, 2026

New Clinical Trial: A Multi-Dimensional Model of cAre and transItion for Patients With cOmplex RAre Diseases (NCT07558213)

WHY IT MATTERS

This trial is testing a coordinated care approach specifically for patients with multiple rare diseases or complex symptoms, which could improve how you receive care across different specialists and reduce the fragmentation many rare disease patients experience.

Researchers are studying a new care model designed to help patients with complex rare diseases get better coordinated treatment and support. The trial involves 136 patients with conditions like mitochondrial diseases and muscular dystrophies. The goal is to bridge the gap between scientific discoveries and actual patient care by creating a more organized system for managing these complicated conditions.

NCT ID: NCT07558213 Status: ACTIVE_NOT_RECRUITING Conditions: Rare Diseases, Mitochondrial Diseases, Muscular Dystrophies, Dysmorphic Disorder, Body Enrollment: 136 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Summary: Over the past century, the progress in biomedical sciences gave outstanding contributions to the understanding of human conditions, and even curing some of them. Recent advances in high-throughput technologies have enabled the profiling of Rare Diseases (RDs) trough genomics, transcriptomics, proteomics, and metabolomics. Regardless of the improvements in the efficiency of data generation, the research community struggles when stepping into bedside and translational processes. The lack of integr

Read the original at clinicaltrials
care coordinationcomplex rare diseasesclinical trialpatient outcomestranslational medicine

Related conditions

Bethlem muscular dystrophyLethal infantile mitochondrial myopathyMitochondrial diseaseFatal mitochondrial disease due to combined oxidative phosphorylation defect type 3Becker muscular dystrophy